Abstract:
Dyslipidemia is a major risk factor of cardiovascular disease. Heavy metal causes abnormal enzyme activity and leading to ischemic heart disease. Many studies found EDTA chelation therapy can excrete heavy metal, decrease inflammation, atherosclerosis, blood pressure and lowering blood cholesterol. The aim of study is to determine the effectiveness of chelation therapy on lowering blood lipid level in hyperlipidemic subject. A total 20 subjects, age 20 to 65 years were enrolled in this study and received chelation once a week for 5 weeks. Most subjects were female (13/20, 65%). The average age was 42 years old. Chelation was able to significantly decrease both the level of total cholesterol (p-value= 0.008) and LDL-cholesterol (p-value= 0.034). However, chelation was not significantly decrease HDL cholesterol, triglyceride, hsCRP and fasting blood sugar.
Conclusion: Chelation was effective on lowering total cholesterol and LDL-cholesterol in hyperlipidemia subject. However, chelation did not decrease HDL cholesterol, triglyceride, hsCRP and fasting blood sugar.